№ lp_1_10233
File format: docx Character count: 32181 File size: 88 KB
This document provides the official product information for Orgalutran, including details on its composition, indications, dosage, and contraindications for use in assisted reproductive techniques.
Year: 2026
Region / City: EMEA
Subject: Pharmaceutical Information
Document Type: Product Information
Organization / Institution: European Medicines Agency
Author: European Medicines Agency
Target Audience: Healthcare Professionals, Medical Practitioners
Validity Period: Not specified
Approval Date: Not specified
Amendment Date: Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Methotrexate, SOLUTION FOR SUBCUTANEOUS INJECTION, PREFILLED SYRINGE, 7.5 MG/0.15 ML, 10 MG/0.2 ML, 15 MG/0.3 ML, 20 MG/0.4 ML, 25 MG/0.5 ML, TREXJECT®
Year: 2023
Region / city: Australia
Topic: Rheumatology, Pharmaceutical Listings
Document type: Submission to Pharmaceutical Benefits Advisory Committee (PBAC)
Organization: Link Medical Products Pty Ltd
Author: Not specified
Target audience: Healthcare professionals, PBAC members
Period of validity: Not specified
Approval date: Not specified
Date of changes: Not specified
Note: Context
Cetrotide 0.25 mg powder and solvent for solution for injection
Year: 2023
Region / city: European Union
Topic: Medicine, Fertility Treatment
Document Type: Product Information
Institution: European Medicines Agency
Author: European Medicines Agency
Target Audience: Healthcare professionals
Effective Period: Not specified
Approval Date: Not specified
Revision Date: Not specified
DE comments on proposed revision of IECEx OD 025 (ExMC/1935/DV)
Year: 2023
Region / City: Sydney, Australia
Topic: Conformity Assessment, IECEx Standards
Document Type: Comment
Organization / Institution: IECEx Secretariat
Author: Raymond Puppan
Target Audience: IECEx Management Committee, ExMC
Period of Validity: Not specified
Approval Date: Not specified
Date of Changes: Not specified
PROJECT PAPER ON A PROPOSED GRANT IN THE AMOUNT OF $0.25 MILLION TO THE GOVERNMENT OF THE REPUBLIC OF ZAMBIA FOR A FORESTRY INVESTMENT PROGRAM INVESTMENT PLAN PROJECT FROM THE FOREST INVESTMENT PROGRAM
Year: 2016
Region / City: Zambia
Theme: Forestry, Environmental Protection, Climate Change
Document Type: Project Paper
Organization: World Bank
Author: World Bank
Target Audience: Government Agencies, Environmental Organizations, Development Partners
Period of Activity: 2016-2018
Approval Date: 2016-07-07
Date of Changes: Not specified
Topics: Orgalutran mg05 025